HomeAI · summaries
Storia in 18 fonti
FDA aprova droga que dobra o tempo de vida de pacientes com câncer de pâncreas avançado
Em um importante ensaio clínico, pacientes que receberam o comprimido daraxonrasib viveram o dobro do tempo daqueles que receberam quimioterapia
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque
Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.
- ·
apnews.com
FDA approves landmark pancreatic cancer drug that's shown to improve survival
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer.
